HomeCompareFFEU vs MRK

FFEU vs MRK: Dividend Comparison 2026

FFEU yields 2.20% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $7.8K in total portfolio value
10 years
FFEU
FFEU
● Live price
2.20%
Share price
$90.85
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$253.79
Full FFEU calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — FFEU vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFFEUMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FFEU + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FFEU pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FFEU
Annual income on $10K today (after 15% tax)
$187.12/yr
After 10yr DRIP, annual income (after tax)
$215.72/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $592.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FFEU + MRK for your $10,000?

FFEU: 50%MRK: 50%
100% MRK50/50100% FFEU
Portfolio after 10yr
$26.8K
Annual income
$602.05/yr
Blended yield
2.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FFEU
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FFEU buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFFEUMRK
Forward yield2.20%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$22.9K$30.7K
Annual income after 10y$253.79$950.29
Total dividends collected$2.4K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FFEU vs MRK ($10,000, DRIP)

YearFFEU PortfolioFFEU Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,920$220.14$11,192$351.54$272.00MRK
2$11,909$224.67$12,524$392.70$615.00MRK
3$12,972$228.99$14,015$438.65$1.0KMRK
4$14,113$233.10$15,682$489.96$1.6KMRK
5$15,338$237.02$17,547$547.23$2.2KMRK
6$16,652$240.74$19,632$611.16$3.0KMRK
7$18,062$244.27$21,963$682.53$3.9KMRK
8$19,574$247.62$24,571$762.18$5.0KMRK
9$21,195$250.79$27,486$851.08$6.3KMRK
10$22,933$253.79$30,745$950.29$7.8KMRK

FFEU vs MRK: Complete Analysis 2026

FFEUStock

The investment seeks return linked to a quarterly rebalanced leveraged participation in the performance of the STOXX Europe 50® USD (Gross Return) Index (the index). At inception the ETN is designed to target two times the performance of the index. A quarterly rebalancing event or a loss rebalancing event will aim to reset the leveraged exposure to the index to approximately two. The index is composed of 50 European blue-chip companies selected from within the STOXX Europe 600 Index.

Full FFEU Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this FFEU vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FFEU vs SCHDFFEU vs JEPIFFEU vs OFFEU vs KOFFEU vs MAINFFEU vs JNJFFEU vs ABBVFFEU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.